Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.

Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL.

Arthritis Res Ther. 2005;7(3):R666-76. Epub 2005 Apr 4.

PMID: 15899052 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2007 Jan;56(1):13-20.

PMID: 17195186 [PubMed - indexed for MEDLINE]

Related Articles

Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis.

Flendrie M, Creemers MC, Welsing PM, den Broeder AA, van Riel PL.

Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii30-3.

PMID: 14532145 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.

Arthritis Rheum. 2007 May;56(5):1417-23.

PMID: 17469098 [PubMed - indexed for MEDLINE]

Related Articles

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.

Kroesen S, Widmer AF, Tyndall A, Hasler P.

Rheumatology (Oxford). 2003 May;42(5):617-21.

PMID: 12709536 [PubMed - indexed for MEDLINE]

Related Articles

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2006 Aug;54(8):2368-76.

PMID: 16868999 [PubMed - indexed for MEDLINE]

Related Articles

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Popa C, van den Hoogen FH, Radstake TR, Netea MG, Eijsbouts AE, den Heijer M, van der Meer JW, van Riel PL, Stalenhoef AF, Barrera P.

Ann Rheum Dis. 2007 Nov;66(11):1503-7. Epub 2007 May 1.

PMID: 17472994 [PubMed - indexed for MEDLINE]

Related Articles

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID: 16705046 [PubMed - indexed for MEDLINE]

Related Articles

Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.

Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.

Arthritis Rheum. 2007 May 15;57(4):679-85.

PMID: 17471545 [PubMed - indexed for MEDLINE]

Related Articles

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.

Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M.

Arthritis Res Ther. 2005;7(2):R250-5. Epub 2005 Jan 10.

PMID: 15743471 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.

Wolfe F, Michaud K.

Arthritis Rheum. 2007 May;56(5):1433-9.

PMID: 17469100 [PubMed - indexed for MEDLINE]

Related Articles

Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.

Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M.

Ann N Y Acad Sci. 2006 Jun;1069:420-7.

PMID: 16855169 [PubMed - indexed for MEDLINE]

Related Articles

Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.

Del Porto F, Laganà B, Lai S, Nofroni I, Tinti F, Vitale M, Podestà E, Mitterhofer AP, D'Amelio R.

Rheumatology (Oxford). 2007 Jul;46(7):1111-5. Epub 2007 Apr 20.

PMID: 17449484 [PubMed - indexed for MEDLINE]

Related Articles

Criteria for TNF-targeted therapy in rheumatoid arthritis: estimates of the number of patients potentially eligible.

Kvien TK, Uhlig T, Kristiansen IS.

Drugs. 2001;61(12):1711-20. Review.

PMID: 11693461 [PubMed - indexed for MEDLINE]

Related Articles

Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.

Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M.

Ann N Y Acad Sci. 2006 Jun;1069:414-9.

PMID: 16855168 [PubMed - indexed for MEDLINE]

Related Articles

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

PMID: 17049139 [PubMed - indexed for MEDLINE]

Related Articles

Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis.

Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ.

Am J Clin Nutr. 2006 Dec;84(6):1463-72.

PMID: 17158431 [PubMed - indexed for MEDLINE]

Related Articles

[Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers]

Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M.

Recenti Prog Med. 2006 Mar;97(3):134-9. Italian.

PMID: 16700418 [PubMed - indexed for MEDLINE]

Related Articles

Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study.

den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, de Waal-Malefijt M, van den Hoogen FH.

J Rheumatol. 2007 Apr;34(4):689-95.

PMID: 17117492 [PubMed - indexed for MEDLINE]

Related Articles

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

Jacobsson LT, Turesson C, Gülfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P.

J Rheumatol. 2005 Jul;32(7):1213-8.

PMID: 15996054 [PubMed - indexed for MEDLINE]

Related Articles